Becton Dickinson reorganized effective Oct 1, 2025 into 5 reportable segments: Medical Essentials,…
Filed with the SEC on · Summarized by InvestorsBot
Becton Dickinson reorganized effective Oct 1, 2025 into 5 reportable segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences. Segments managed separately; principal product lines unchanged. 🔁 $BDX #MedTech #Healthcare
On July 13, 2025 $BDX agreed to combine its Biosciences & Diagnostic Solutions business with Waters Corporation. After separation/combination the Life Sciences segment will be eliminated and BD will report four segments. 🤝 $WAT #M&A #BDX
BD furnished Exhibit 99.1 with recast FY2025 and quarterly segment revenues under the new structure. Exhibit includes non‑GAAP measures/adjustments (see schedules) and is "furnished" — not Section 18 filed. 📊 $BDX #SECfiling #Investing